Your browser doesn't support javascript.
loading
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo, N; Gadducci, A; Sehouli, J; Rulli, E; Mäenpää, J; Sessa, C; Montes, A; Ottevanger, N B; Berger, R; Vergote, I; D'Incalci, M; Churruca Galaz, C; Chekerov, R; Nyvang, G B; Riniker, S; Herbertson, R; Fossati, R; Barretina-Ginesta, M P; Deryal, M; Mirza, M R; Biagioli, E; Iglesias, M; Funari, G; Romeo, M; Tasca, G; Pardo, B; Tognon, G; Rubio-Pérez, M J; DeCensi, A; De Giorgi, U; Zola, P; Benedetti Panici, P; Aglietta, M; Arcangeli, V; Zamagni, C; Bologna, A; Westermann, A; Heinzelmann-Schwarz, V; Tsibulak, I; Wimberger, P; Poveda, A.
Affiliation
  • Colombo N; Gynecologic Cancer Program, European Institute of Oncology IRCCS and University of Milan-Bicocca, Milan, Italy.
  • Gadducci A; Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
  • Sehouli J; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Gynecology with Center for Oncological Surgery, European Competence Center for Ovarian Cancer, Charité-Berlin University of Medicine, Berlin, Germany.
  • Rulli E; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Mäenpää J; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Obstetrics and Gynaecology and Tays Cancer Centre Tampere University and University Hospital, Tampere, Finland.
  • Sessa C; Istituto Oncologico della Svizzera Italiana, IOSI and Swiss Group for Clinical Cancer Research (SAKK), Bellinzona, Switzerland.
  • Montes A; Guys and St Thomas' NHS Foundation Trust, London, UK.
  • Ottevanger NB; Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Berger R; Medical University of Innsbruck, Department for Gynecology and Obstetrics, Innsbruck, Austria, and AGO, Innsbruck, Austria.
  • Vergote I; Gynecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Belgian Gynaecological Oncology Group (BGOG), European Union, Leuven, Belgium.
  • D'Incalci M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Churruca Galaz C; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Chekerov R; Hospital de Donosti San Sebastián and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain.
  • Nyvang GB; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Gynecology with Center for Oncological Surgery, European Competence Center for Ovarian Cancer, Charité-Berlin University of Medicine, Berlin, Germany.
  • Riniker S; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Herbertson R; Oncology, Kantonsspital St. Gallen and Swiss Group for Clinical Cancer Research (SAKK), St. Gallen, Switzerland.
  • Fossati R; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
  • Barretina-Ginesta MP; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Deryal M; Institut Catalá de Oncología de Girona and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain.
  • Mirza MR; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and CaritasKlinikum St. Theresia-Saarbruecken, Saarbruecken, Germany.
  • Biagioli E; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU) & Department of Cancer Treatment, Copenhagen University Hospital, Copenhagen, Denmark.
  • Iglesias M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. elena.biagioli@marionegri.it.
  • Funari G; Hospital Son Llázter and Grupo Español de Cáncer de Ovario (GEICO), Palma, Spain.
  • Romeo M; Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
  • Tasca G; Institut Catalá de Oncología de Badalona and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain.
  • Pardo B; Oncologia 2, Istituto Oncologico Veneto, Padua, Italy.
  • Tognon G; Institut Catalá de Oncología de Hospitalet and Grupo Español de Cáncer de Ovario (GEICO), Barcelona, Spain.
  • Rubio-Pérez MJ; Obstetrics and Gynaecology, ASST Spedali Civili-Università degli Studi di Brescia, Brescia, Italy.
  • DeCensi A; Hospital Reina Sofía Córdoba and Grupo Español de Cáncer de Ovario (GEICO), de Donosti San, Spain.
  • De Giorgi U; S.C. Oncologia Medica, E.O. Ospedali Galliera, Genoa, Italy.
  • Zola P; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Benedetti Panici P; AOU Città della Salute e della Scienza - OIRM S. Anna, Torino, Italy.
  • Aglietta M; AOU Policlinico Umberto I di Roma, Rome, Italy.
  • Arcangeli V; Istituto di Candiolo, FPO-IRCCS and University of Torino, Torino, Italy.
  • Zamagni C; Ospedale Infermi, Rimini, Italy.
  • Bologna A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Westermann A; Azienda Unità Sanitaria Locale di Reggio Emilia IRCCS, Reggio Emilia, Italy.
  • Heinzelmann-Schwarz V; Amsterdam UMC, Amsterdam, Netherlands.
  • Tsibulak I; Universitätsspital Basel, USB andSwiss Group for Clinical Cancer Research (SAKK), Basel, Switzerland.
  • Wimberger P; Medical University of Innsbruck, Department for Gynecology and Obstetrics, Innsbruck, Austria, and AGO, Innsbruck, Austria.
  • Poveda A; North Eastern German Society of Gynecological Oncology (NOGGO) Study group and Department of Gynecology and Obstetrics, Technische Universität Dresden, Fetscherstr, Dresden, Germany.
Br J Cancer ; 128(8): 1503-1513, 2023 04.
Article in En | MEDLINE | ID: mdl-36759720
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Clinical_trials / Etiology_studies / Guideline Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Clinical_trials / Etiology_studies / Guideline Limits: Female / Humans Language: En Journal: Br J Cancer Year: 2023 Document type: Article Affiliation country: